123 AZACITIDINE (AZA) COMBINED WITH IDARUBICIN (IDA) IN HIGHER RISK MDS (HRMDS) – RESULTS OF A PHASE I/II STUDY BY THE GFM. Issue 1 (April 2015) - Sebert, M.; Ades, L.; Stamatoullas, A.; Braun, T.; Delaunay, J.; de Renzis, B.; Jeddi, R.; Meddeb, B.; Berger, M. Hunault; Samey, B.; Chermat, F.; Chaffaut, C.; et al.